Author:
Mohri Kiminori,Okada Kenji,Benet Leslie Z.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference24 articles.
1. 1. C. H. Cashin, W. Dawson, and E. A. Kitchen. The pharmacology of benoxaprofen (2-[4-chlorophenyl]-alpha-methyl-5-benzoxazole acetic acid), LRCL 3794, a new compound with antiinflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J. Pharm. Pharmacol. 29:330?336 (1977).
2. 2. K. Tsurumi, K. Kyuki, T. Nakayama, and H. Fujimura. Antiinflammatory properties of benoxaprofen. Oyo Yakuri 19:555?567 (1980).
3. 3. K. Tsurumi, K. Kyuki, H. Mibu, Y. Togawa, and H. Fujimura. Supplement to anti-inflammatory properties of benoxaprofen. Oyo Yakuri 23:651?659 (1982).
4. 4. A. Duthie, A. Nicholls, M. Freeth, P. Moorhead, and D. Triger. Fatal cholestatic jaundice in elderly patients taking benoxaprofen. Br. Med. J. [Clin. Rea.] 285:62 (1982).
5. 5. Mohri, Okada, and Benet 84.5. B. M. Goudie. G. F. Birnie, G. Watkinson, R. N. Macsween, L. H. Kissen, and N. E. Cunningham. Jaundice associated with the use of benoxaprofen. Lancet 1:959 (1982).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献